MS-DRG v38 (FY 2021) Definitions Manual • DRG 847 - CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC

DRG Information as of MS-DRG v38 (FY 2021)

MDCMDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms
MDC SubsectionChemotherapy without Acute Leukemia as Secondary Diagnosis
DRG Number847
DRG DescriptionCHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC
Surgical / Medical Medical

Table 5 for FY 2021

Weights1.3341
Length of Stay (Geometric Mean)3.6
Length of Stay (Arithmetic Mean)4.1
Special Pay DRGNo
Post-Acute DRGNo

DRG Assignment Logic (From MDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms Subsection Chemotherapy without Acute Leukemia as Secondary Diagnosis)

This DRG is a member of the subsection Chemotherapy without Acute Leukemia as Secondary Diagnosis. Patients who qualify for Chemotherapy without Acute Leukemia as Secondary Diagnosis will be grouped this DRG or one of the related DRGs according to the logic below.

View the requirements to qualify.

Quick Actions